METHOD FOR SELECTING A METHOD FOR TREATING PATIENTS WITH CATARACTS AND OPEN-ANGLE GLAUCOMA WITH UNDERLYING PSEUDOEXFOLIATION SYNDROME Russian patent published in 2022 - IPC A61F9/07 A61F9/08 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely, to ophthalmology. The intolerance index, the coefficient of intraocular fluid outflow facility, and the values of intraocular pressure are determined, and the order of treatment of cataracts and glaucoma is determined in accordance with said values. If the intolerance index is 0 or lower, the coefficient of intraocular fluid outflow facility is 0.15 mm³/mmHg*min or higher, and the intraocular pressure decreases to values not exceeding the value of individually tolerated pressure against the background of hypotensive therapy with b-adrenergic blockers and/or carbonic anhydrase inhibitors, then the first stage is phacoemulsification of the cataracts, and the next stage of microinvasive non-penetrating sclerectomy is performed a month after the cataract phacoemulsification if values of high intraocular pressure exceeding the values of individually tolerated intraocular pressure are reached. If values of intraocular pressure not exceeding the values of individually tolerated intraocular pressure are reached, selective laser trabeculoplasty is performed. If the intolerance index is 0 or lower, the coefficient of intraocular fluid outflow facility is 0.1 to 0.15 mm3/mmHg*min, and the intraocular pressure decreases to values not exceeding the value of individually tolerated pressure against the background of hypotensive therapy with b-adrenergic blockers and/or carbonic anhydrase inhibitors, then the first stage is selective laser trabeculoplasty, and the next stage of phacoemulsification of the cataracts including a stage of hydrodynamic trabeculocleaning is performed a month after the first stage. If the intolerance index is above 0, the coefficient of intraocular fluid outflow facility is below 0.1 mm³/mmHg*min, and the intraocular pressure decreases to values exceeding the value of individually tolerated pressure against the background of hypotensive therapy with b-adrenergic blockers and/or carbonic anhydrase inhibitors, then the first stage is microinvasive non-penetrating sclerectomy, and the next stage of phacoemulsification of the cataracts is performed a month after. If true values of intraocular pressure exceeding the value of individually tolerated pressure are reached between the stages of treatment or in the postoperative period, the patient is additionally prescribed hypotensive therapy in order to reduce the high intraocular pressure to values not exceeding the value of individually tolerated pressure.

EFFECT: possibility of selecting a method for treating patients with cataracts and glaucoma with underlying pseudoexfoliation syndrome, saving time, and preventing postoperative complications.

1 cl, 3 ex